Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways

DE NOVO PYRIMIDINE BIOSYNTHETIC PATHWAY (PW:0000862)

View Ontology Report

Description

Mammalian de novo pyrimidine biosynthesis is accomplished by six enzymatic activities, encoded by only three genes - two encode multifunctional proteins. In the de novo synthesis of pyrimidines, the pyrimidine ring is added to the ribose-5-phosphate after the ring has been generated, unlike purines. The first reaction of the six-step pathway to generate uridine monophosphate (UMP) is catalyzed by the carbamoyl phosphate synthetase II activity of the trifunctional cytosolic mammalian enzyme Cad,

Pathway Diagram:

Ariadne Genomics Inc. deoxyribonucleotide metabolic pathway nucleotide sugar biosynthetic pathway Nme members hexosamine biosynthetic pathway transcription pathway phosphatidylcholine biosynthetic pathway ATP ADP UTP UDP UMP PRPP CTP CDP CTP ---> CDP UDP ---> UTP Cmpk1 UMP ---> UDP Cmpk2 Ctps2 Ctps PRPP --+> Umps Umps orotidine-5'-P ---> CO2 CO2 orotidine-5'-P ---> UMP PRPP ---> PPi PPi orotate ---> orotidine-5'-P ubiquinone ---> ubiquinol ubiquinol ubiquinone dihydroorotate ---> orotate HCO3- L-glutamate ureidosuccinate ---> H2O H2O ureidosuccinate ---> dihydroorotate Pi Sspartate L-glutamine ---> carbamoyl-P L-glutamine ATP ---> L-glutamate ATP ---> ADP HCO3- ---> ADP carbamoyl-P ---> ureidosuccinate Sspartate ---> Pi UDP ---> deoxyribonucleotide metabolic pathway CDP ---> deoxyribonucleotide metabolic pathway UTP ---> nucleotide sugar biosynthetic pathway CTP ---> transcription pathway UTP ---> transcription pathway CTP ---> phosphatidylcholine biosynthetic pathway UTP ---> hexosamine biosynthetic pathway orotidine-5'-P orotate dihydroorotate ureidosuccinate carbamoyl-P ATP --+> Cad PRPP --+> Cad UMP ---| Umps UDP ---| Cad UTP ---| Cad UTP ---> CTP Dhodh Cad
GO TO:

Genes in Pathway:


show annotations for term's descendants           Sort by:
de novo pyrimidine biosynthetic pathway term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase ISO RGD PMID:15096496 RGD:5133412 NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297
JBrowse link
G Cmpk1 cytidine/uridine monophosphate kinase 1 ISO RGD PMID:12678497 RGD:5133414 NCBI chr 5:133,717,073...133,744,623
Ensembl chr 5:133,717,086...133,744,596
JBrowse link
G Cmpk2 cytidine/uridine monophosphate kinase 2 IDA RGD PMID:192455 RGD:5133256 NCBI chr 6:48,802,150...48,813,652
Ensembl chr 6:48,802,321...48,813,652
JBrowse link
G Ctps1 CTP synthase 1 ISO RGD PMID:12678497 RGD:5133414 NCBI chr 5:139,372,349...139,440,441
Ensembl chr 5:139,410,249...139,440,465
JBrowse link
G Ctps2 CTP synthase 2 ISO RGD PMID:20739275 RGD:5133419 NCBI chr  X:35,277,658...35,418,505
Ensembl chr  X:35,277,658...35,418,505
JBrowse link
G Dhodh dihydroorotate dehydrogenase ISO RGD PMID:15096496 RGD:5133412 NCBI chr19:54,460,636...54,483,049
Ensembl chr19:54,468,690...54,514,496
JBrowse link
G Nme1 NME/NM23 nucleoside diphosphate kinase 1 ISO RGD PMID:11768308 RGD:5134680 NCBI chr10:79,403,939...79,426,620
Ensembl chr10:79,403,940...79,413,310
JBrowse link
G Nme2 NME/NM23 nucleoside diphosphate kinase 2 ISO RGD PMID:11768308 RGD:5134680 NCBI chr10:79,394,999...79,400,418
Ensembl chr20:11,179,066...11,179,497
Ensembl chr10:11,179,066...11,179,497
JBrowse link
G Nme3 NME/NM23 nucleoside diphosphate kinase 3 ISO RGD PMID:11768308 RGD:5134680 NCBI chr10:14,421,922...14,422,878
Ensembl chr10:14,421,702...14,422,907
JBrowse link
G Nme4 NME/NM23 nucleoside diphosphate kinase 4 ISO RGD PMID:11768308 RGD:5134680 NCBI chr10:15,619,106...15,622,961
Ensembl chr10:15,619,106...15,623,098
JBrowse link
G Nme6 NME/NM23 nucleoside diphosphate kinase 6 ISO RGD PMID:11768308 RGD:5134680 NCBI chr 8:118,708,092...118,717,756
Ensembl chr 8:118,711,036...118,718,288
JBrowse link
G Umps uridine monophosphate synthetase ISO RGD PMID:15096496 RGD:5133412 NCBI chr11:80,311,269...80,321,678
Ensembl chr11:80,311,214...80,327,828
JBrowse link

Additional Elements in Pathway:

(includes Gene Groups, Small Molecules, Other Pathways..etc.)
Object TypePathway ObjectPathway Object Description
Small MoleculeADPadenosine diphosphate
Small MoleculeATPadenosine triphosphate
Small MoleculeCDPcytidine diphosphate
Small MoleculeCTPcytidine triphosphate
Functional ClassNme membersmembers of the nucleoside diphosphate kinase family
Small MoleculePRPPphosphoribosyl pyrophosphate
Small MoleculeUDPuridine diphosphate
Small MoleculeUMPuridine monophosphate
Small MoleculeUTPuridine triphosphate

Pathway Gene Annotations

Disease Annotations Associated with Genes in the de novo pyrimidine biosynthetic pathway
Disease TermsGene Symbols
arteriosclerosisNme2
beta thalassemiaCad , Dhodh , Umps
biliary tract benign neoplasmCtps1
breast cancerNme1
breast carcinomaNme1
Breast NeoplasmsUmps
CardiomegalyNme1
cardiomyopathyUmps
Chemical and Drug Induced Liver InjuryNme2
Colonic NeoplasmsCad , Umps
colorectal cancerCtps2
Colorectal NeoplasmsNme1 , Nme2 , Umps
congenital hypoplastic anemiaCad , Umps
congestive heart failureNme2
Coronary Artery Disease, Autosomal Dominant 2Cad
COVID-19Nme1
Desbuquois dysplasiaDhodh
developmental and epileptic encephalopathy 1Cad
developmental and epileptic encephalopathy 50Cad
Drug-Related Side Effects and Adverse ReactionsUmps
epilepsyCad
erythroleukemiaCad , Dhodh , Umps
Experimental ArthritisDhodh
Experimental Autoimmune NeuritisDhodh
Experimental Diabetes MellitusCad , Dhodh , Umps
Experimental Liver NeoplasmsCad , Dhodh
Experimental Mammary NeoplasmsCad
Fetal Growth RetardationCad
genetic diseaseCad , Dhodh , Umps
Germ Cell and Embryonal NeoplasmsNme2
hepatocellular carcinomaCad , Nme1 , Umps
hereditary breast ovarian cancer syndromeNme1
hereditary spherocytosisCad , Dhodh , Umps
hypertrophic cardiomyopathyNme1
HypoxiaNme1
Idiopathic Basal Ganglia Calcification 10Cmpk2
Immediate HypersensitivityDhodh
immunodeficiency 24Ctps1
Laterality Defects, Autosomal DominantCtps2
lung non-small cell carcinomaCmpk1
Lymphatic MetastasisNme1 , Nme2
Meniere's diseaseCad
MesotheliomaNme2
Mouth NeoplasmsUmps
multiple sclerosisCmpk2
Nasopharyngeal NeoplasmsCtps1
Neoplasm InvasivenessNme1
Neoplasm MetastasisNme1 , Nme2
neuroblastomaNme1
orotic aciduriaUmps
Orotic Aciduria IIUmps
osteoarthritisNme2
ovarian cancerNme1 , Nme2
ovarian carcinomaNme2
Ovarian NeoplasmsNme2
ovary epithelial cancerNme1
pancreatic ductal carcinomaNme1
postaxial acrofacial dysostosisDhodh
prostate carcinomaNme1
prostatic hypertrophyNme2
Prostatic NeoplasmsUmps
purine-pyrimidine metabolic disorderUmps
renal cell carcinomaCad , Nme1
rhabdomyosarcomaCad
sickle cell anemiaCad , Dhodh , Umps
Skin NeoplasmsNme2
squamous cell carcinomaNme1 , Umps
Stomach NeoplasmsUmps
teratomaNme1 , Nme2
Transplant RejectionDhodh
urinary bladder cancerNme1 , Nme2
Pathway Annotations Associated with Genes in the de novo pyrimidine biosynthetic pathway
Pathway TermsGene Symbols
2-hydroxyglutaric aciduria pathwayCad
adefovir pharmacokinetics pathwayNme1 , Nme2
adenine phoshoribosyltransferase deficiency pathwayNme6
adenosine monophosphate deaminase deficiency pathwayNme6
adenylosuccinate lyase deficiency pathwayNme6
AICA-ribosuria pathwayNme6
alanine, aspartate and glutamate metabolic pathwayCad
azathioprine pharmacodynamics pathwayNme6
beta-ureidopropionase deficiency pathwayCad , Cmpk2 , Ctps1 , Dhodh , Nme6 , Umps
Canavan disease pathwayCad
cardiolipin metabolic pathwayNme4
de novo pyrimidine biosynthetic pathwayCad , Cmpk1 , Cmpk2 , Ctps1 , Ctps2 , Dhodh , Nme1 , Nme2 , Nme3 , Nme4 , Nme6 , Umps
dihydropyrimidinase deficiency pathwayCad , Cmpk2 , Ctps1 , Dhodh , Nme6 , Umps
E-cadherin signaling pathwayNme1
gemcitabine pharmacodynamics pathwayCmpk1 , Ctps1 , Nme1
gemcitabine pharmacokinetics pathwayCmpk1 , Ctps1 , Nme1
Glut1 deficiency syndrome pathwayCmpk1 , Nme2
glutamic acid/glutamate metabolic pathwayCad
homocarnosinosis pathwayCad
Kelley-Seegmiller syndrome pathwayNme6
lactose biosynthetic pathwayCmpk1 , Nme2
lamivudine pharmacokinetics pathwayCmpk1 , Nme1
Lesch-Nyhan syndrome pathwayNme6
mercaptopurine pharmacodynamics pathwayNme6
mitochondrial neurogastrointestinal encephalopathy syndrome pathwayCad , Cmpk2 , Ctps1 , Dhodh , Nme6 , Umps
molybdenum cofactor deficiency pathwayNme6
orotic aciduria 1 pathwayCad , Cmpk2 , Ctps1 , Dhodh , Nme6 , Umps
purine metabolic pathwayNme1 , Nme2 , Nme3 , Nme4 , Nme6
purine nucleoside phosphorylase deficiency pathwayNme6
pyrimidine metabolic pathwayCad , Cmpk1 , Cmpk2 , Ctps1 , Ctps2 , Dhodh , Nme1 , Nme2 , Nme3 , Nme4 , Nme6 , Umps
succinic semialdehyde dehydrogenase deficiency pathwayCad
tenofovir pharmacokinetics pathwayNme1 , Nme2
tioguanine pharmacodynamics pathwayNme6
xanthinuria type I pathwayNme6
xanthinuria pathwayNme6
xanthinuria type II pathwayNme6
Phenotype Annotations Associated with Genes in the de novo pyrimidine biosynthetic pathway
Phenotype TermsGene Symbols
decreased metastatic potentialNme2

References Associated with the de novo pyrimidine biosynthetic pathway:

Ontology Path Diagram:

paths to the root
paths to the root

Import into Pathway Studio: